BBVA
Banco Bilbao Vizcaya Argentaria’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6M | Buy |
147,880
+4,511
| +3% | +$567K | 0.17% | 115 |
|
|
2025
Q1 | $15.9M | Buy |
143,369
+3,699
| +3% | +$409K | 0.16% | 126 |
|
|
2024
Q4 | $19.1M | Buy |
139,670
+915
| +0.7% | +$125K | 0.2% | 105 |
|
|
2024
Q3 | $16M | Hold |
138,755
| – | – | 0.16% | 125 |
|
|
2024
Q2 | $19.1M | Hold |
138,755
| – | – | 0.2% | 103 |
|
|
2024
Q1 | $19.1M | Hold |
138,755
| – | – | 0.22% | 101 |
|
|
2023
Q4 | $18.3M | Hold |
138,755
| – | – | 0.22% | 105 |
|
|
2023
Q3 | $15.6M | Hold |
138,755
| – | – | 0.21% | 108 |
|
|
2023
Q2 | $13.1M | Buy |
138,755
+5,022
| +4% | +$474K | 0.17% | 134 |
|
|
2023
Q1 | $13.5M | Hold |
133,733
| – | – | 0.17% | 127 |
|
|
2022
Q4 | $16M | Hold |
133,733
| – | – | 0.23% | 98 |
|
|
2022
Q3 | $14.2M | Hold |
133,733
| – | – | 0.23% | 87 |
|
|
2022
Q2 | $13M | Hold |
133,733
| – | – | 0.2% | 109 |
|
|
2022
Q1 | $13.2M | Hold |
133,733
| – | – | 0.18% | 113 |
|
|
2021
Q4 | $11.3M | Buy |
+133,733
| New | +$11.3M | 0.15% | 132 |
|
|
2020
Q3 | – | Sell |
-5,000
| Closed | -$610K | – | 731 |
|
|
2020
Q2 | $610K | Hold |
5,000
| – | – | 0.02% | 514 |
|
|
2020
Q1 | $432K | Buy |
+5,000
| New | +$432K | 0.02% | 515 |
|